雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Lymphoproliferative Disease in Inflammatory Bowel Disease Kazuichi Okazaki 1 , Norimasa Fukata 1 , Yugo Ando 1 , Mika Oomiya 1 , Takashi Okazaki 1 , Akiko Kurishima 1 , Mitsunobu Matsushita 1 1The Third Department of Internal Medicine, Division of Gastroenterology and Hepatology, Kansai Medical University, Hirakata, Japan Keyword: 炎症性腸疾患 , 血液リンパ増殖症 , LPD , 免疫調節薬 , インフリキシマブ pp.763-769
Published Date 2013/5/24
DOI https://doi.org/10.11477/mf.1403113822
  • Abstract
  • Look Inside
  • Reference

 In the patients with IBD(inflammatory bowel disease), such as ulcerative colitis and Crohn's disease in overseas, the possibility of inducing LPD(lymphoproliferative disorders)by long-term use of thiopurine(6-MP, Azathiopurine)or anti-TNF-alpha antibody has been reported, although it is conflicting because of some reports denying such possibility. On the other hand, by reviewing Japanese literatures or the national study of questionnaire by the research committee for the intractable intestinal disease supported by the Ministry of Health, Labour and Welfare, the risk of LPD may be not related with using thiopurines, but unknown by anti-TNF-antibody in Japanese patients with IBD. Further studies are needed to clarify this issue.


Copyright © 2013, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1882-1219 印刷版ISSN 0536-2180 医学書院

関連文献

もっと見る

文献を共有